SCHEMBL4025840

SCHEMBL4025840

Cc1ncsc1C(=O)NCc1cc(F)ccc1F

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CHRM4 P08173 1/20 0.53
HSD17B13 Q7Z5P4 3/20 0.49
AR P10275 3/20 0.48
NR3C1 P04150 1/20 0.47
MET P08581 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
HTR7 P34969 1/20 0.43
KMT2A Q03164 1/20 0.43
ROCK2 O75116 1/20 0.43
ROCK1 Q13464 1/20 0.43
HPGD P15428 1/20 0.43
ENPP2 Q13822 1/20 0.41
MAPK8 P45983 1/20 0.41
KDM4E B2RXH2 1/20 0.41
PKM P14618 1/20 0.41
NAMPT P43490 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4205317 0.90 HSD17B13 (0.60) CHRM4HSD17B13ARNR3C1MET
SCHEMBL4559627 0.82 SMN1; SMN2 (0.60) CHRM4SMN1; SMN2L3MBTL1KMT2AHPGD
SCHEMBL4030640 0.81 SMN1; SMN2 (0.54) CHRM4ARMETSMN1; SMN2L3MBTL1
SCHEMBL3048657 0.73 SMN1; SMN2 (0.59) CHRM4SMN1; SMN2L3MBTL1KDM4EPKM
SCHEMBL3562274 0.73 ALDH1A1 (0.48) CHRM4METHTR7ROCK2ROCK1
SCHEMBL15222555 0.72 CHRM4 (0.74) CHRM4
SCHEMBL9314231 0.72 GAA (0.60) SMN1; SMN2L3MBTL1KMT2A
SCHEMBL21101550 0.72 PKM (0.56) SMN1; SMN2L3MBTL1KMT2AHPGDKDM4E
SCHEMBL4329523 0.72 CNR1 (0.45) CHRM4METROCK2ROCK1
SCHEMBL16945275 0.70 CHRM4 (0.48) CHRM4METHTR7KMT2AROCK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2054408-A2 HETEROCYCLIC COMPOUNDS SUITABLE FOR THE TREATMENT OF DISEASES RELATED TO ELEVATED LIPID LEVEL Novartis Ag (CH) 2009-05-06 EP disclosed
WO-2008127349-A2 HETEROCYCLIC COMPOUNDS SUITABLE FOR THE TREATMENT OF DISEASES RELATED TO ELEVATED LIPID LEVEL NOVARTIS AG (CH) 2008-10-23 WO disclosed